Primary or adjuvant radiotherapy or chemo-radiotherapy are part of the curative treatment regime in head and neck squamous cell carcinoma (HNSCC). However, in >50% of high-risk patients, treatment resistance leads to loco-regional disease persistence or recurrence. Metastasis to regional lymph nodes is one of the strongest prognostic factors in HNSCC. By using artificial intelligence (AI)-based … Continue reading Immune cell interaction in primary tumour and lymph nodes driven by head and neck cancers, with a focus on immunoglobulin-producing B cells